Expertise in
17
conditions

Dr. Firas Zahr

Cardiology
University Of Iowa Stead Family Children's Hospital
200 Hawkins Dr, 
Iowa City,, IA 
Clinical Trials:Currently Recruiting for 1 Trial
Referral required
Before you request
Expertise in
17
conditions
University Of Iowa Stead Family Children's Hospital
200 Hawkins Dr, 
Iowa City,, IA 

Overview

Firas Zahr is a Cardiologist practicing medicine in Iowa City,, Iowa.

Dr. Zahr is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Mitral Valve Regurgitation, Aortic Valve Stenosis, Tricuspid Regurgitation, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

He is actively involved in clinical research, co-authoring 139 peer reviewed articles and participating in 13 clinical trials.

Specialties

Cardiology

Licenses

Internal Medicine in OH

Hospital Affiliations

Columbia Memorial Hospital
Ohsu Hospital And Clinics

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
BridgeSpan
  • EPO
  • HMO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Moda Health
  • EPO
  • PPO
PacificSource
  • PPO
Prominence Health
  • EPO
  • PPO
Regence
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

University of Iowa Stead Family Children's Hospital
200 Hawkins Dr, Iowa City,, IA 52242
Other Locations
University Andrology Lab LLC
3303 S Bond Ave, Portland,, OR 97239

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO Trial
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO Trial
Enrollment Status: Recruiting
Publish Date: May 19, 2026
Intervention Type: Device
Study Phase: Not Applicable
Edwards EVOQUE Tricuspid Valve Replacement: Investigation of Safety and Clinical Efficacy After Replacement of Tricuspid Valve With Transcatheter Device
Edwards EVOQUE Tricuspid Valve Replacement: Investigation of Safety and Clinical Efficacy After Replacement of Tricuspid Valve With Transcatheter Device
Enrollment Status: Active_not_recruiting
Publish Date: May 08, 2026
Intervention Type: Device
Study Phase: Not Applicable
Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement
Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement
Enrollment Status: Active_not_recruiting
Publish Date: May 07, 2026
Intervention Type: Device
Study Phase: Not Applicable
Transcatheter Aortic Valve Replacement (TAVR) With Medtronic TAVR System in Patients With Severe Bicuspid Aortic Valve Stenosis and at Low Predicted Risk of Mortality With Surgical Aortic Valve Replacement (SAVR)
Transcatheter Aortic Valve Replacement (TAVR) With Medtronic TAVR System in Patients With Severe Bicuspid Aortic Valve Stenosis and at Low Predicted Risk of Mortality With Surgical Aortic Valve Replacement (SAVR)
Enrollment Status: Active_not_recruiting
Publish Date: May 05, 2026
Intervention Type: Device
Study Phase: Not Applicable
Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance After Mitral Valve Replacement With Transcatheter Device (MISCEND)
Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance After Mitral Valve Replacement With Transcatheter Device (MISCEND)
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Device
Study Phase: Not Applicable
Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation
Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation
Enrollment Status: Active_not_recruiting
Publish Date: April 09, 2026
Intervention Type: Device
Study Phase: Not Applicable
Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device
Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device
Enrollment Status: Active_not_recruiting
Publish Date: February 27, 2026
Intervention Type: Device, Drug
Study Phase: Not Applicable
Edwards PASCAL TrAnScatheter Valve RePair System in Tricuspid Regurgitation (CLASP TR) Early Feasibility Study
Edwards PASCAL TrAnScatheter Valve RePair System in Tricuspid Regurgitation (CLASP TR) Early Feasibility Study
Enrollment Status: Completed
Publish Date: September 29, 2025
Intervention Type: Device
Study Phase: Not Applicable
Early Feasibility Study Of the Edwards APTURE Transcatheter Shunt System (ALT-FLOW US)
Early Feasibility Study Of the Edwards APTURE Transcatheter Shunt System (ALT-FLOW US)
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2025
Intervention Type: Device
Study Phase: Not Applicable
A U.S. Post-Approval Study of the SYNERGY 4.50/5.00 mm Everolimus-Eluting Platinum Chromium Coronary Stent System (Evolve 4.5/5.0)
A U.S. Post-Approval Study of the SYNERGY 4.50/5.00 mm Everolimus-Eluting Platinum Chromium Coronary Stent System (Evolve 4.5/5.0)
Enrollment Status: Completed
Publish Date: December 14, 2023
Intervention Type: Device
View 9 Less Clinical Trials

139 Total Publications

Right Ventricular Function and Echocardiographic Characteristics After Left Atrial to Coronary Sinus Shunting; Insights from ALT-FLOW Early Feasibility Study 3 Year Follow-Up.
Right Ventricular Function and Echocardiographic Characteristics After Left Atrial to Coronary Sinus Shunting; Insights from ALT-FLOW Early Feasibility Study 3 Year Follow-Up.
Journal: Journal of cardiac failure
Published: May 10, 2026
Similar Doctors
Expertise in
64
conditions
Dr. Nicolas W. Shammas
Cardiology | Interventional Cardiology
Expertise in
64
conditions
Dr. Nicolas W. Shammas
Cardiology | Interventional Cardiology
Referral may be required
Before you request

Cardiovascular Medicine, P.C. - Davenport

1236 E. Rusholme St. Heart Institute, Suite 300, 
Davenport, IA 
 (1621.7 miles away)
800-382-0707
Languages Spoken:
English
See accepted insurances

Nicolas W. Shammas, MD - Cardiology, Interventional & Peripheral Cardiology, TAVR. Dr. Shammas is highly rated in 64 conditions, according to our data. His clinical expertise encompasses Peripheral Artery Disease, Atherosclerosis, Venous Insufficiency, Atherectomy, and Angioplasty. Dr. Shammas is board certified in Interventional Cardiology, American Board Of Interventional Cardiology.

Expertise in
28
conditions
Dr. Alexandros Briasoulis
Advanced Heart Failure and Transplant Cardiology | Cardiology
Expertise in
28
conditions
Dr. Alexandros Briasoulis
Advanced Heart Failure and Transplant Cardiology | Cardiology
Referral may be required
200 Hawkins Drive, 
Iowa City, IA 
 (1570.8 miles away)
319-678-8418
Languages Spoken:
English

Alexandros Briasoulis is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist practicing medicine in Iowa City, Iowa. Dr. Briasoulis is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Heart Failure, Cardiac Amyloidosis, Primary Amyloidosis, Heart Transplant, and Aortic Valve Replacement.

Expertise in
3
conditions
Expertise in
3
conditions
Referral may be required
Before you request

University Of Iowa Stead Family Children's Hospital

200 Hawkins Dr, 
Iowa City, IA 
 (1570.8 miles away)
319-356-3642
Languages Spoken:
English
See accepted insurances

Robert Felder is a Cardiologist practicing medicine in Iowa City, Iowa. Dr. Felder is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Necrosis, Heart Failure, Hypertension, and Heart Attack.

Frequently Asked Questions about Dr. Firas Zahr

How do I make an appointment with Dr. Firas Zahr?

You can book an appointment with Dr. Firas Zahr by calling their office at 319-356-2737. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Firas Zahr a top-rated expert for Mitral Valve Regurgitation?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Firas Zahr is classified as an Elite expert for Mitral Valve Regurgitation, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Firas Zahr specialize in?

While Dr. Firas Zahr is a Cardiology, they have specific expertise in Mitral Valve Regurgitation, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Stenosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Cardiology.

Does Dr. Firas Zahr participate in research or clinical trials?

Yes. Dr. Firas Zahr has published 139 articles and abstracts on conditions like Mitral Valve Regurgitation. You can view a list of Dr. Firas Zahr's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Firas Zahr accept my insurance?

Dr. Firas Zahr accepts most major insurance plans, including Anthem BCBS and BridgeSpan. We recommend calling the office directly at 319-356-2737 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Zahr's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 25 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile